Clorox Reports Q3 Fiscal Year 2017 Results; Updates Fiscal Year 2017 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Clorox (CLX) PT Lowered to $136 at Jefferies Following Soft 3Q
May 4, 2017 9:40 AM EDTJefferies lowered its price target on Clorox (NYSE: CLX) to $136.00 (from $138.00) while maintaining a Hold rating. CLX delivered an EPS beat at $1.31 vs. $1.30, highlighted by organic sales and GM% misses, driving a 6% OI miss in the quarter.
CLX's guidance now calls for... More
Clorox (CLX) Tops Q3 EPS by 1c; Updates Outlook
May 3, 2017 6:32 AM EDTClorox (NYSE: CLX) reported Q3 EPS of $1.31, $0.01 better than the analyst estimate of $1.30. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.48 billion.
Clorox now anticipates fiscal year 2017 diluted EPS from continuing operations in the range of $5.25 to $5.35, an... More



